Acute Mitral Regurgitation Follow-up
- Author: Daniel DiSandro, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP more...
Further Outpatient Care
The definitive treatment of mitral regurgitation remains surgery.
The risk-benefit ratio must be examined carefully with each individual situation prior to a decision to replace the valve.
The 2 primary surgeries are mitral valve replacement and mitral valve repair.
If treated early enough, mitral valve repair is the optimal choice (lower risk of infectious endocarditis and better postoperative left ventricular function).
Repair usually is available only to those whose condition has a nonrheumatic, noninfectious, and nonischemic cause; therefore, candidates for mitral valve repair are few.
Valve replacement should not be undertaken in asymptomatic patients.
Early recognition of even minimal symptoms is crucial in order to attempt to preserve as much left ventricular function as possible.
Chordal transection during replacement surgery results in some impairment of left ventricle function; thus, the more left ventricular function prior to surgery, the better the outcome.
Patients must be educated concerning the warning signs and symptoms (eg, congestive heart failure, chest pain) and should be advised to see their physician early in the course of the disorder, before symptoms progress.
[Guideline] Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Sep 23. 52(13):e1-142. [Medline]. [Full Text].
Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation. 2003 Nov 18. 108(20):2432-8. [Medline].
Carabello BA. Management of valvular regurgitation. Curr Opin Cardiol. 1995 Mar. 10(2):124-7. [Medline].
Carabello BA. Mitral valve disease. Curr Probl Cardiol. 1993 Jul. 18(7):423-78. [Medline].
Fenster MS, Feldman MD. Mitral regurgitation: an overview. Curr Probl Cardiol. 1995 Apr. 20(4):193-280. [Medline].
Filsoufi F, Salzberg SP, Adams DH. Current management of ischemic mitral regurgitation. Mt Sinai J Med. 2005 Mar. 72(2):105-15. [Medline].
Gaasch WH, Eisenhauer AC. The management of mitral valve disease. Curr Opin Cardiol. 1996 Mar. 11(2):114-9. [Medline].
Schon HR. Medical treatment of chronic valvular regurgitation. J Heart Valve Dis. 1995 Oct. 4 Suppl 2:S170-4. [Medline].
Wisenbaugh T. Mitral valve disease. Curr Opin Cardiol. 1994 Mar. 9(2):146-51. [Medline].
Zito C, Manganaro R, Khandheria B, et al. Usefulness of left atrial reservoir size and left ventricular untwisting rate for predicting outcome in primary mitral regurgitation. Am J Cardiol. 2015 Oct 15. 116(8):1237-44. [Medline].
Arsalan M, Squiers JJ, DiMaio JM, Mack MJ. Catheter-based or surgical repair of the highest risk secondary mitral regurgitation patients. Ann Cardiothorac Surg. 2015 May. 4(3):278-83. [Medline].